Status and phase
Conditions
Treatments
About
This is a multicenter, randomized, double-blind, dose finding, parallel controlled with active drug and placebo, phase II clinical trial, and the purpose of the study is to evaluate the efficacy and safety of HR18042 tablets for postoperative analgesia after impacted teeth removal surgery.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
180 participants in 5 patient groups, including a placebo group
Loading...
Central trial contact
Qin Liu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal